PHD reader domains are chromatin binding modules often responsible for the recruitment of large protein complexes that contain histone modifying enzymes, chromatin remodelers and DNA repair machinery. PHD domains recognize N-terminal residues of histone H3 and are sensitive to the methylation state of Lys4 in histone H3 (H3K4). Histone demethylase KDM5A, an epigenetic eraser enzyme that contains three PHD domains, is often overexpressed in various cancers and its demethylation activity is allosterically enhanced when its PHD1 domain is bound to the H3 tail. The allosteric regulatory function of PHD1 expands roles of reader domains, suggesting unique features of this chromatin interacting module. Our previous studies determined the H3 binding site of PHD1, although it remains unclear how the H3 tail interacts with the N-terminal residues of PHD1 and how PHD1 discriminates against H3 tails with varying degrees of H3K4 methylation. Here we show that the N-terminal region of PHD1 is initially unstructured, but becomes ordered upon binding of the high affinity H3 peptide ligands. We also observe differential interactions of conserved binding residues with differently methylated H3K4 peptides (me0, me1, me2 or me3), providing a rational for this PHD1 domain's preference for lower methylation states of H3K4.
Introduction
Histone modifications play a central role in regulating chromatin structure and function.
Protein reader domains recognize specific histone modifications and are often responsible for recruiting large protein complexes that contain histone modifying enzymes, chromatin remodelers and DNA repair machinery 1 . Plant homeodomain (PHD) domains are specific for recognizing the N-terminal residues of histone H3 and read the methylation state of H3K4 and, to a lesser extent, H3R2 2 . While the majority of PHD domains recognize H3, recognition of H4 peptides has been observed in extended PHD domains in MLL3/4 3, 4 .
The conserved PHD fold consists of a two strand β-sheet, a C-terminal α-helix and two structural zinc atoms stabilized by a Cys4-His-Cys3 motif 2 . Depending on the residues involved, different PHD domains preferentially engage H3 as a function of the methylation status of H3K4. H3K4me3 preferring PHD domains, such as BPTF 5 and TAF3 6 , have two to four aromatic residues that form an aromatic cage in the H3K4 binding pocket which allows for cation-π interactions with tri-methylated H3K4 7 (Figure 1a) . Inclusion of a H3K4 interacting glutamate residue in the aromatic cage of PHF20-PHD leads to the specificity for H3K4me2 8 . PHD domains that preferentially bind unmodified H3K4, such as BHC80 9 and AIRE 10,11 , lack an aromatic cage, but instead have a H3K4 binding pocket consisting of both acidic and hydrophobic residues. Specificity for unmodified H3K4 is achieved by electrostatic and hydrogen bond interactions. These domains discriminate against methylated H3K4 residues by steric occlusion of H3K4 methyl groups from the binding pocket in addition to an increase in cationic radius and decrease in hydrogen bond potential 9-14 .
Members of the KDM5 family are H3K4me3 specific demethylases and contain varying number of PHD domains. All four members of the KDM5 family are involved in pathogenesis and progression of various cancers [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] and other, particularly neurological, disorders 31, 32 .
For this reason there is significant interest in developing therapeutics targeting these enzymes [33] [34] [35] [36] [37] . KDM5A specifically is overexpressed in breast cancer, where it promotes cancer progression and metastasis 38 , and there is evidence for its role in resistance to endocrine therapy 39 as well as cancer drug resistance in lung cancer models 40 . KDM5A contains three PHD domains. Its PHD3 domain is specific for H3K4me3 and it is thought to be responsible for recruiting KDM5A to the site of its substrate. PHD3 is also known to form a fusion with NUP98 in acute leukemia 15 . We have previously shown that the PHD1 domain preferentially binds unmodified H3 41 and that the engagement of the PHD1 domain with its ligand allosterically enhances the demethylation activity of KDM5A by stabilizing substrate binding to the catalytic domain 42 . Despite the importance of PHD1 in the demethylase activity of KDM5A, there is limited structural information on how its PHD1 domain interacts with H3 and how it can discriminate against the methylation states of H3K4 peptides. We have previously mapped the unmodified H3 peptide binding site of PHD1 using NMR 41 . Also important structural insights have been gained from studies performed on the PHD1 domain of homologue KDM5B 12,13 . However, questions remain about the interactions of the Nterminal region of the PHD1 domain, which was absent in the construct used in our previous NMR studies, as well as how peptide binding residues of this reader domain interact with methylated H3 peptides.
Here we show that the N-terminal segment of PHD1 is flexible and becomes structured upon peptide binding and that residues in this region interact strongly with the peptide. These interactions are modulated by the methylation status of H3K4, as we observe differential engagement of this region with differently methylated peptides. Peptide binding residues in PHD1 were further probed through mutagenesis. Structural information of this regulatory reader domain will contribute to knowledge of how PHD domains interact with their ligands. Additionally, given the allosteric role of this domain in regulation of KDM5A catalysis, structural information could assist in the development of unique allosteric small molecule ligands for use as chemical tools. This would allow for pharmacological interrogation of the role of this enzyme in KDM5A dependent disorders.
Methods

Expression and purification of WT and variant GST-PHD1.
WT and variant PHD1 constructs (S287-K347) were cloned into a pET41a vector and expressed in BL21(DE3) E. coli cells. Expression and purification of WT and variants followed the same protocol. Cells were induced with 0.4 mM IPTG and grown at 18 °C overnight before the pellet was collected. The cells were resuspended in lysis buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 5 mM β-mercaptoethanol, 50 µM 
Fluorescence polarization binding assays.
The binding of GST-PHD1 to H3 10mer peptides was measured by either direct or competition-based fluorescence polarization (FP). For direct FP binding assay, 10 nM of Cterminal fluorescein labeled H3 10mer peptide were incubated for 30 mins with varying concentrations of GST-PHD1. Data from direct FP measurements were fitted to equation 1:
For competition-based FP assays, GST-PHD1, at a concentration equal to the K d for unmodified H3 peptide, was incubated with 10 nM of C-terminal fluorescently labeled H3 10mer peptide and different concentrations of unlabeled peptides were used as competitors.
Data from competition-based FP assays were fitted to equation 2:
where FP obs is the observed FP, FP max is the maximum FP value, FP min is the minimum FP value, [PHD1] is concentration of GST-PHD1, K d is the dissociation constant, K i is the inhibition constant referring to the competing peptide and [I] is the competing peptide concentration.
Nuclear magnetic resonance experiments.
A PHD1 construct encompassing residues S287-E344 was used in NMR studies. The GST-PHD1 fusion construct was expressed in M9 minimal media containing 15 
Results and Discussion
Unstructured N-terminal residues participate in H3 peptide recognition PHD1 preferentially binds unmodified H3 peptides and the binding affinity decreases with an increase in H3K4 methylation 41, 42 . Based on previous studies with the PHD1 domain of the demethylase KDM5B (PHD1 KDM5B ), the predicted H3K4 binding pocket consists of conserved residues Asp292, Tyr294 and Leu310 12,13 (Figure 1a,d) . We previously mapped the H3 peptide binding site of PHD1 KDM5A domain using two-dimensional heteronuclear single quantum coherence (2D 15 N-HSQC) NMR titration experiments 41 . However, these experiments did not detect any interaction between the H3 peptide and a conserved H3K4 binding pocket residue, Asp292, in the PHD1 construct used (Asp292-Glu344). Our recent fluorescence polarization-based binding studies suggested that Asp292 is involved in binding when an N-terminally extended PHD1 construct (Ser287-Lys347) is used 42 . This observation prompted us to examine the contribution of these N-terminal residues to peptide binding and, additionally, to H3K4 methyl recognition.
In order to assess binding of the H3 peptide to PHD1, 2D 15 N HSQC experiments were conducted using a PHD1 (Ser287-Glu344) construct. The HSQC spectrum of apo PHD1 showed a well-dispersed set of peaks, consistent with a well-structured domain, which were assigned to individual residues using NMR triple-resonance backbone experiments (Figure   1b ). Comparison of the HSQC spectra of Ser287-Glu344 with Asp292-Glu344, which we previously used, showed several overlapping peaks (Supplementary Figure 1) , but a significant shift in many residues suggests structural differences between the two constructs.
The H3 10mer peptide binding site in the Ser287-Glu344 PHD1 construct was identified by NMR peptide titration experiments (Figure 1b ). Large chemical shifts were observed, many undergoing slow-intermediate exchange on the NMR timescale, indicating a strong interaction (low-micromolar affinity). The largest shifts were found to occur in the N-terminal region (Asp292-Val295), residues preceding the first β-strand (Glu305, Asp306), the first βstrand itself (Leu308-Cys311) and following residues, which are part of the second Zn finger (Gly313, Asp315) (Figure 1c) . Additionally, residues near the C-terminal were also perturbed (Val330, Trp335). These residues were mapped onto a generated I-TASSER homology model 43 of PHD1, and all these clustered to the same face of PHD1. Overlaying the H3 peptide bound NMR structure of the PHD1 KDM5B 13 with our homology model showed that the residues with the largest chemical shifts changes coincided with the peptide binding region of PHD1 KDM5B (Figure 1d) . Large shifts in Asp292, Tyr294, and their adjacent residues, not seen in studies with Asp292-Glu344 PHD1, indicate the importance of these residues in H3 binding. Similar trends have been observed in NMR studies of AIRE 10 and the PHD1 KDM5B 12, 13 . In PHD1 KDM5B large chemical shifts occur in the first β-sheet and residues before the C-terminal α-helix 12,13 . However, there are differences in the chemical shift perturbations of the N-terminal residues between the two studies, likely due to constructs and peptides used.
In the absence of the H3 ligand, the chemical shifts values of the N-terminal residues (Val288-Tyr294) of PHD1 suggest that they are unstructured (Figure 1b) 
Differential engagement with methylated H3K4 peptides by PHD1
Methylation of H3K4 greatly impacts the affinity of the H3 peptide for PHD1 with an increase in the number of methyl groups on H3K4 resulting in decreased affinity 41 . Interestingly, PHD1 KDM5A domain is still able to bind all three methylated states of H3K4 ( HSQC NMR titration measurements were performed with H3K4me1, H3K4me2 and H3K4me3 peptides (Figure 2a, b, c) . For all three methylated peptides we see the presence of NMR signals indicating fast exchange on the NMR timescale, suggesting weaker interactions than with unmodified H3. However, H3K4me1 still contains a large number of signals in slow-intermediate exchange on the NMR timescale suggesting strong interactions, comparable to with unmodified H3. We observe that similar residues are engaged upon binding of unmodified and methylated H3 peptides, implying the binding site used is similar overall (Figure 2d) . However, significant differences in the behavior of specific residues show alternate interactions are made with methylated peptides.
When the H3K4me1 peptide is bound, the majority of peak shifts are similar to those on binding to the unmodified peptide (Figure 2d, e; pink bars) . However, with monomethylation some residues are affected to a lesser degree with the largest decreases in chemical shift changes occurring for residues Val291-Leu293, which includes the H3K4 binding pocket residue Asp292 (Figure 2f) Binding of H3K4me3 causes a large reduction in the chemical shift perturbations, relative to unmodified H3. The largest differences in chemical shift changes between the unmodified and tri-methylated ligand occur in residues that form the H3K4 binding pocket (Val291-Tyr294) and in residues around the first β-strand (E305-D315) (Figure 2d, e; blue bars) .
The reduced interaction of the Val291-Tyr294 region with the peptide is likely due to the bulky nature of the H3K4me3 side chain in the H3K4 binding pocket. The biggest changes occur with Asp292, likely due to the inability of H3K4me3 to form a hydrogen bond with Asp292. In contrast to Asp292, Tyr294 and Leu310 show smaller differences in the magnitudes of their chemical shift perturbations between the tri-methylated and unmodified ligand, suggesting that these residues are more likely to interact with the alkyl chain of H3K4, rather than its ε-amino group.
Interestingly, upon H3K4me3 binding, three residues (Cys296, Met297 and Cys299) undergo increased perturbation compared to unmodified H3 binding. These residues are part of the first Zn-finger and are positioned on a loop underneath the H3K4 binding pocket (Figure 2g) . We hypothesize that upon binding of the H3K4me3 group, the chemical environment of these residues is perturbed due to the structural changes needed to accommodate the bulky group and allowing it to occupy the H3K4 binding pocket (Figure   2f ).
Together our NMR data indicates that, of the H3K4 binding pocket residues, Asp292 is the most sensitive to the methylation state of the peptides as we see much larger decreases in the chemical shift perturbations of this amino acid as the methylation state increases. This is 
Assessing the interactions of H3K4 binding pocket residues
Our NMR data have provided insights into the interactions of the H3K4 binding pocket and differently methylated H3 peptides. In order to further assess the role of the H3K4 binding pocket residues (Asp292, Tyr294 and Leu310) in H3 peptide binding and methyl recognition we mutated these residues and measured H3 peptide binding to PHD1.
Mutation of Asp292 to Ala decreases the affinity of PHD1 for H3 ∼6-fold relative to WT ( Table 1) . It also reduces binding to H3K4me1/2/3 peptides, with a 4-fold reduction for the interaction with H3K4me1 and ∼2-fold reduction for higher methylation states. This decreased dependence on the presence of the carboxylate for binding higher methylation states of the peptide is consistent with a decrease in hydrogen bonding capacity of H3K4 and consistent with our chemical shift perturbation measurements (Figure 2) .
D292N PHD1 has a similar affinity to D292A with similar fold-reductions for the unmodified and H3K4me1 peptides likely due to the removal of the electrostatic interaction between the Asp292 and H3K4 side chains ( Table 1) . K d values for binding of the H3K4me2 peptide to the D292N mutant differ from those of D292A, but overall show a much reduced affinity relative to the WT PHD1. However, the K d for H3K4me3 binding to the D292N mutant is similar to WT values, suggesting that the negative charge of the aspartate is not as important in H3K4me3 binding, but that other side chain contacts likely are.
When Tyr294 was mutated to an Ala, a ∼15-fold decrease in affinity for the unmodified H3
peptide was observed as well as a reduced affinity for methylated peptides, consistent with our NMR data (Table 1 and Figure 2) . Unlike the Y294A mutation, replacement of this residue with Phe diminishes binding of unmodified and mono-methylated peptides by <3fold, with a minimal impact on binding of di-and tri-methylated peptides. These findings suggest the importance of hydrophobic and π-cation interactions between Lys4 and the aromatic ring of Tyr294. This is supported by the NMR structure of PHD1 KDM5B , as the ε-CH 2 of Lys4 is directed towards the Tyr294 ring (Figure 2f ) consistent with preferred engagement of the ε-CH 2 group of lysine in π-cation interactions 47, 48 . In addition, tri-methylated lysine has been shown to enhance these interactions with aromatic residues 49 . L310A shows greatly reduced binding affinity for the unmodified and methylated H3 peptides, with a nearly 60-fold decrease in affinity for the unmodified H3 peptide. This is consistent with observations of a large chemical shift perturbation of Leu310 upon peptide binding. The equivalent residue in PHD1 KDM5B (Leu326) interacts both with H3K4 and H3R2 residues in the H3 peptide, and as such is a major contributor to peptide binding.
Together our data indicate that, of the K4 binding pocket residues, Leu310 contributes the most to the binding affinity, followed by Tyr294 and Asp292. These data suggest a finely tuned binding site with varying, methylation-dependent, contributions to H3 binding and H3K4 methyl discrimination. However, the contributions of these residues to binding may not be conserved between KDM5 family PHD1 domains. Mutations of H3K4 binding pocket residues in PHD1 KDM5B , Y310 and L326 (Y294 and L310 in KDM5A) resulted in ∼2 and 4fold lower affinity for unmodified H3 peptides was compared to WT 13 . In contrast, we observe much larger changes upon mutation of these residues, ∼15 to 60-fold change, in PHD1 KDM5A , suggesting differential interactions with H3 exist with the PHD1 domains of KDM5A and KDM5B, despite their high sequence similarity.
The role of H3 peptide interacting residues in PHD1
We have shown previously that interaction of H3R2 with PHD1 is a major contributor to the high affinity of PHD1 for H3 41 . Mutation of the conserved R2 interacting residues Asp312 and Asp315 greatly impacts binding, with Asp312 being essential for binding. Additionally, we have previously shown that the conserved Trp residue in PHD domains (Figure 1a) , Trp335 in PHD1, likely interacts with the N-terminus of the peptide. However, it is unknown what contributions, if any, other residues of H3 might have to the overall binding affinity. To address this question, we mutated several H3 interacting residues predicted by our homology model and the structural information available for PHD1 KDM5B 13 (Figure 1) , and subsequently measured the affinity of mutants for the H3 peptide.
Val330 is predicted to form hydrophobic interactions with H3T3 (Figure 3b ). Mutating this residue to an alanine reduced the affinity 3.5-fold (Figure 3a) . Similar K d values of the WT and V330A PHD1 towards methylated H3 peptides suggest that the interaction between
Val330 and H3T3 has a significant contribution only to the binding of the highest affinity unmodified H3 peptide ligand. Glu305 is predicted to hydrogen bond to both H3T3 and H3Q5 (Figure 3b) . Mutation of this residue to Ala results in ∼6-fold reduction in affinity for both unmodified and mono-methylated H3K4 (Figure 3a, b) suggesting this residue makes significant interactions with the H3 peptide. The smaller decrease in affinity observed with H3K4me2 and me3 suggests a decreased dependence on interactions of these peptides with Glu305. Val295 and Asn303 in PHD1 are predicted to form hydrophobic interactions with H3T6 (Figure 3b) We have also shown that E305 is an important H3 binding residue and the introduction of a positive lysine residue, as in the E305K disease mutation, would affect PHD1 interactions with H3. K d values of PHD1 peptide binding pocket variants binding to differently methylated H3K4 10mer peptides. b) Location of residues mutated in the study, shown in the structure of the PHD1 domain of KDM5B (PDB ID: 2MNZ). PHD1 KDM5B is shown in cyan, the H3 peptide is shown in yellow.
Summary
Overall, our findings provide an understanding of how PHD1 KDM5A recognizes H3 tail residues and discriminates against H3K4 methylation. Using NMR, we observe that an initially unstructured N-terminal region interacts strongly with H3 peptides and becomes more structured upon ligand binding (Figure 1) . Significantly reduced interactions of the Nterminal residues with methylated H3K4 peptides further highlights the importance of this region in regulating the methylation selectivity in PHD1. We also identify the interactions that allow PHD1 to interact with relatively high affinity to methylated H3K4 peptides, a property that makes PHD1 KDM5A , so far, unique when compared to related PHD domains. Given the allosteric role of this reader domain in KDM5A demethylase activity, our findings also provide insights into how mutations in this domain would impact allosteric ligand binding and therefore modulate activity of KDM5A. The greater understanding of the structural features of PHD1 and H3 binding provided here will facilitate development of PHD1-targeting small molecule modulators of KDM5A for use as chemical tool compounds. 
